# The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device

> **NCT03006055** · PHASE3 · UNKNOWN · sponsor: **Beijing Viroad Biotechnology Co., Ltd.** · enrollment: 190 (estimated)

## Conditions studied

- Circulating Tumor Cells.Breast

## Interventions

- **DEVICE:** Circulating tumor cells

## Key facts

- **NCT ID:** NCT03006055
- **Lead sponsor:** Beijing Viroad Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2017-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006055, "The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03006055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*